Google invests $100 million in Amwell as the telehealth provider moves to Google Cloud services

August 28, 2020
Digital Transformation More...
Very important

Google's role in healthcare analytics has been documented in digital therapeutics and through hospital systems like Ascension. It is now looking to telehealth as an additional pillar in its healthcare strategy by partnering with Amwell. Google is likely seeing Amwell as a strong player as one of the three biggest telehealth companies in the U.S., but it should be wary. In order to survive against competitors, Amwell will need a consumer-facing remote monitoring solution to compete with rival Teladoc, which just partnered with Livongo. With its recent cash influx from both Google and COVID-19 hype, clients can view Amwell as an opportune target for remote monitoring sales.

For the original news article, click here .

Further Reading

Sanofi backs out from its digital diabetes and cardiovascular programs

News Commentary | December 17, 2019

This announcement effectively ends Sanofi's partnership with Onduo, a joint venture with Verily. Back in 2016, both Verily and Sanofi invested half a billion dollars in this ambitious program, with Sanofi execs touting this as an example of their commitment to digital health innovation. Onduo has ... Not part of subscription

Withings raises $60 million in Series B funding

News Commentary | July 28, 2020

Withings, which develops and sells connected health products like smart scales, sleep trackers, and blood pressure cuffs, intends to use this latest funding round to scale its B2B sales model. This funding is coming at a time when connected devices are very important for providing physical metrics ... Not part of subscription

Personalized nutrition startup GenoPalate raises $4 million Series A round

News Commentary | January 04, 2021

GenoPalate intends to use the funding to double its customer capacity to at least 3,000 people daily. Sales growth for personalized nutrition startups appears to be flourishing, with multiple CEOs citing record sales in 2020 to Lux. GenoPalate could very well be on a similar trajectory. Moving into ... Not part of subscription